Appointments and Second Opinions

Speak with one of our New Patient Coordinators to schedule an appointment, refer a patient or request a second opinion. In urgent cases, we can typically see new patients within 24 hours.

Contact us
Find Clinical Trials

We sponsor and collaborate on clinical trials that break new ground in pediatric cancer and blood disorder treatment. 

Search Pediatric Cancer and Blood Disorder Clinical Trials
Our Affiliations
HMS Affiliate

Dana-Farber/Boston Children's is a teaching affiliate of Harvard Medical School.

Our Affiliations

Christopher John Recklitis, PhD, MPH

  • Director of Research, Perini Family Survivors' Center
  • Senior Psychologist
  • Associate Professor of Pediatrics, Harvard Medical School

Office Phone

  • 617-632-5124

Fax

  • 617-582-8068

General

Treatment Centers

Discipline

Clinical Interests

Health psychology, Mental health outcomes of oncology patients

Location

Background

Board Certifications

  • Certified Health Care Provider
  • Licensed Psychologist

Fellowship

  • Boston Children's Hospital, Pediatric Health Services Research
  • Harvard School of Public Health, Clinical Effectiveness

Biography

Christopher J. Recklitis, Ph.D., MPH is Director of Research and Support Services for the Perini Family Survivors Center at Dana-Farber, and Associate Professor of Pediatrics at Harvard Medical School. He completed doctoral degree in clinical psychology at Boston University, and his Masters in Public Health at the Harvard School of Public Health. Dr. Recklitis's research is focused on understanding the psychological late-effects of cancer, the development of effective screening measures for detecting distress, and the best methods for encouraging health protective behaviors in cancer survivors. He is the Principal Investigator of Project REACH, a longitudinal study of health outcomes in several hundred locally treated cancer survivors. His work has been supported by grants from the National Cancer Institute, Lance Armstrong Foundation, American Foundation for the Prevention of Suicide, and the Childhood Brain Tumor Foundation.